Meredith Ian T 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
- Exercise/Conversion
Common Stock
2022-02-17+1,250→ 32,871 total - Exercise/Conversion
Restricted Stock Units
2022-02-17−1,250→ 3,750 totalExp: 2025-02-17→ Common Stock (1,250 underlying) - Tax Payment
Common Stock
2022-02-17$42.83/sh−367$15,719→ 32,504 total - Exercise/Conversion
Common Stock
2022-02-18+1,037→ 33,541 total - Tax Payment
Common Stock
2022-02-18$42.55/sh−305$12,978→ 33,236 total - Exercise/Conversion
Deferred Stock Units
2022-02-18−1,037→ 2,076 totalExp: 2024-02-18→ Common Stock (1,037 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.